Title : Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.

Pub. Date : 2014 Jan

PMID : 23811849






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The absence of HMGB1 expression by dying tumor cells exposed to anthracyclines or oxaliplatin compromises DC-dependent T-cell priming by tumor-associated antigens. Anthracyclines high mobility group box 1 Homo sapiens